• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与低核仁素表达的L929细胞相比,对载有多柔比星的磁性PLGA-PEG纳米球靶向递送至C6胶质瘤细胞的研究与评估。

Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.

作者信息

Mosafer Jafar, Teymouri Manouchehr, Abnous Khalil, Tafaghodi Mohsen, Ramezani Mohammad

机构信息

Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

School of Medicine, Gonabad University of Medical Sciences, Gonabad, Iran.

出版信息

Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:123-133. doi: 10.1016/j.msec.2016.11.053. Epub 2016 Nov 16.

DOI:10.1016/j.msec.2016.11.053
PMID:28024568
Abstract

Magnetic nanoparticulate systems based on polymeric materials such as poly (lactic-co-glycolic acid) (PLGA) are being studied for their potential applications in targeted therapy and imaging of malignant tumors. In the current study, superparamagnetic iron oxide nanocrystals (SPIONs) and doxorubicin (Dox) were entrapped in the PLGA-based nanoparticles via a modified multiple emulsion solvent evaporation method. Furthermore, SPIO/Dox-NPs were conjugated to anti-nucleolin AS1411 aptamer (Apt) and their targeting ability was investigated in high nucleolin-expressing C6 glioma cells compared to low nucleolin-expressing L929 cells. The NPs exhibited a narrow size distribution with mean diameter of 170nm and an appropriate SPION content (18% of total polymer weight) with a sufficient saturation magnetization value of 5.9emu/g which is suitable for imaging objectives. They manifested an increased Dox release at pH5.5 compared to pH7.4, with initial burst release (within 24h) followed by sustained release of Dox for 36days. The Apt conjugation to NPs enhanced cellular uptake of Dox in C6 glioma cells compared to L929 cells. Similarly, the Apt-NPs increased the cytotoxicity effect of Dox compared with NPs and Dox solution (f-Dox) alone. In conclusion, the Apt-NPs were found to be a promising delivery system for therapeutic and diagnostic purposes.

摘要

基于聚(乳酸 - 乙醇酸)(PLGA)等聚合物材料的磁性纳米颗粒系统因其在恶性肿瘤靶向治疗和成像中的潜在应用而受到研究。在本研究中,通过改进的复乳溶剂蒸发法将超顺磁性氧化铁纳米晶体(SPIONs)和阿霉素(Dox)包裹在基于PLGA的纳米颗粒中。此外,将SPIO/Dox-NPs与抗核仁素AS1411适配体(Apt)偶联,并与低核仁素表达的L929细胞相比,在高核仁素表达的C6胶质瘤细胞中研究其靶向能力。这些纳米颗粒呈现出窄的尺寸分布,平均直径约为170nm,具有合适的SPION含量(约占聚合物总重量的18%),饱和磁化强度值为5.9emu/g,足以满足成像目的。与pH7.4相比,它们在pH5.5时Dox释放增加,最初有突发释放(24小时内),随后Dox持续释放36天。与L929细胞相比,Apt与纳米颗粒的偶联增强了C6胶质瘤细胞对Dox的细胞摄取。同样,与单独的纳米颗粒和Dox溶液(游离Dox)相比,Apt-纳米颗粒增加了Dox的细胞毒性作用。总之,发现Apt-纳米颗粒是一种有前途的用于治疗和诊断目的的递送系统。

相似文献

1
Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.与低核仁素表达的L929细胞相比,对载有多柔比星的磁性PLGA-PEG纳米球靶向递送至C6胶质瘤细胞的研究与评估。
Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:123-133. doi: 10.1016/j.msec.2016.11.053. Epub 2016 Nov 16.
2
In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.载有阿霉素的抗核仁素靶向磁性聚乳酸-羟基乙酸共聚物纳米粒作为一种用于增强靶向癌症成像和治疗的诊疗剂的体外和体内评价
Eur J Pharm Biopharm. 2017 Apr;113:60-74. doi: 10.1016/j.ejpb.2016.12.009. Epub 2016 Dec 21.
3
Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.细胞表面核仁素作为一种有前景的受体,可实现AS1411适配体介导的有效靶向药物递送至癌细胞。
Curr Drug Deliv. 2018;15(9):1323-1329. doi: 10.2174/1567201815666180724104451.
4
Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods.不同乳化溶剂挥发法制备的超顺磁性氧化铁/阿霉素共载聚乳酸-羟基乙酸纳米球的比较研究。
Artif Cells Nanomed Biotechnol. 2018 Sep;46(6):1146-1155. doi: 10.1080/21691401.2017.1362415. Epub 2017 Aug 9.
5
Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.载多柔比星的具有 pH 响应性和适体功能化的聚合物(聚 D,L-乳酸-共-乙醇酸)纳米粒增强癌症治疗。
Arch Biochem Biophys. 2019 Aug 15;671:143-151. doi: 10.1016/j.abb.2019.07.004. Epub 2019 Jul 5.
6
Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.用于肺癌治疗的载有阿霉素的星形共聚物聚乳酸-羟基乙酸共聚物-维生素E TPGS纳米颗粒
J Mater Sci Mater Med. 2015 Apr;26(4):165. doi: 10.1007/s10856-015-5498-z. Epub 2015 Mar 20.
7
Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.适配体功能化的 PEG-PLGA 纳米粒用于增强抗脑胶质瘤药物传递。
Biomaterials. 2011 Nov;32(31):8010-20. doi: 10.1016/j.biomaterials.2011.07.004. Epub 2011 Jul 23.
8
AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.AS1411 适配体标记的 PLGA-大豆卵磷脂-PEG 纳米粒用于肿瘤细胞靶向和药物递送。
Biotechnol Bioeng. 2012 Nov;109(11):2920-31. doi: 10.1002/bit.24558. Epub 2012 Jun 1.
9
Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.用于阿霉素靶向递送的生物素共轭多层聚[D,L-丙交酯-共-乙交酯]-卵磷脂-聚乙二醇纳米颗粒
J Pharm Sci. 2016 Sep;105(9):2949-2958. doi: 10.1016/j.xphs.2016.03.038. Epub 2016 May 18.
10
[Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].阿霉素负载聚乳酸-羟基乙酸共聚物纳米粒的处方及工艺优化及其体外释放
Yao Xue Xue Bao. 2013 May;48(5):759-66.

引用本文的文献

1
AS1411 Aptamer-Conjugated Liposomal siRNA Targeting MTA2 Suppresses PI3K/AKT Signaling in Pancreatic Cancer Cells.靶向MTA2的AS1411适配体偶联脂质体siRNA抑制胰腺癌细胞中的PI3K/AKT信号传导。
Int J Mol Sci. 2025 Aug 30;26(17):8467. doi: 10.3390/ijms26178467.
2
Light-Promoted Lysosomal Escape of a Phthalocyanine and Antisense Oligonucleotide-Complexed G-Quadruplex for Dual Photodynamic and Antisense Therapy.用于双光动力和反义治疗的酞菁与反义寡核苷酸复合G-四链体的光促进溶酶体逃逸
ACS Pharmacol Transl Sci. 2024 Sep 25;7(10):3216-3227. doi: 10.1021/acsptsci.4c00384. eCollection 2024 Oct 11.
3
Aptamer-functionalized nanomaterials (AFNs) for therapeutic management of hepatocellular carcinoma.
适配体功能化纳米材料(AFNs)用于肝细胞癌的治疗管理。
J Nanobiotechnology. 2024 May 12;22(1):243. doi: 10.1186/s12951-024-02486-5.
4
DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors.基于DNA的纳米材料作为药物递送平台以增强药物在肿瘤中的疗效。
Cancers (Basel). 2023 Apr 5;15(7):2151. doi: 10.3390/cancers15072151.
5
Strategies for developing long-lasting therapeutic nucleic acid aptamer targeting circulating protein: The present and the future.开发针对循环蛋白的长效治疗性核酸适配体的策略:现状与未来。
Front Cell Dev Biol. 2022 Nov 1;10:1048148. doi: 10.3389/fcell.2022.1048148. eCollection 2022.
6
A Review on Nanocarrier Mediated Treatment and Management of Triple Negative Breast Cancer: A Saudi Arabian Scenario.纳米载体介导的三阴性乳腺癌治疗与管理综述:沙特阿拉伯的情况
Front Oncol. 2022 Jul 22;12:953865. doi: 10.3389/fonc.2022.953865. eCollection 2022.
7
Targeting lung cancer cells with MUC1 aptamer-functionalized PLA-PEG nanocarriers.用 MUC1 适体功能化的 PLA-PEG 纳米载体靶向肺癌细胞。
Sci Rep. 2022 Mar 18;12(1):4718. doi: 10.1038/s41598-022-08759-z.
8
A Tri-Stimuli Responsive (Maghemite/PLGA)/Chitosan Nanostructure with Promising Applications in Lung Cancer.一种具有肺癌应用前景的三刺激响应性(磁赤铁矿/聚乳酸-羟基乙酸共聚物)/壳聚糖纳米结构
Pharmaceutics. 2021 Aug 10;13(8):1232. doi: 10.3390/pharmaceutics13081232.
9
Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment.核仁素靶向 AS1411 适体修饰的胶束共载多柔比星和 miR-519c 提高肝癌治疗疗效。
Int J Nanomedicine. 2021 Mar 30;16:2569-2584. doi: 10.2147/IJN.S304526. eCollection 2021.
10
Preparation, characterization and evaluation of alginate-coated chitosan and trimethylchitosan nanoparticles loaded with PR8 influenza virus for nasal immunization.负载PR8流感病毒的海藻酸盐包被壳聚糖和三甲基壳聚糖纳米颗粒用于鼻腔免疫的制备、表征及评价
Asian J Pharm Sci. 2019 Mar;14(2):216-221. doi: 10.1016/j.ajps.2018.04.005. Epub 2018 May 10.